
Madopar
Madopar
Product Description
Madopar Dispersible Tabs (Co-beneldopa) 125mg (100)
Indicated in Parkinsonism - idiopathic, post-encephalitic. Previous neurosurgery is not a contraindication to Madopar. Patients requiring a more rapid onset of action, e.g. patients suffering from early morning or afternoon akinesia, or who exhibit 'delayed on' or 'wearing off' phenomena are more likely to benefit from Madopar Dispersible.Directions
Available on request.Ingredients
Available on request.Product Details
Form:Dispersible tabletFridge-line:NoToxin:NoPOM:YesLegal Category:POMFiller:NoStorage Temperature:N/AManufacturer:N/A